James Pannucci

USPTO Granted Patents = 15 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Frederick, MD (US) (2018)
Reston, VA (US) (2016 - 2024)

Company Filing History:

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

1 out of 915

The University of New Mexico

patents

where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370258 - PD-1 and CTLA-4 dual inhibitor peptides (2025-07-29),

2. 12269880 - LAG3 binding peptides (2025-04-08),

3. 11987646 - Immunomodulatory peptides (2024-05-21),

4. 11793856 - PD-1 peptide inhibitors (2023-10-24),

5. 11578102 - LAG3 binding peptides (2023-02-14),

6. 11407829 - LAG3 binding peptides (2022-08-09),

7. 11338040 - Immunomodulatory compounds (2022-05-24),

8. 11033622 - PD-1 and CTLA-4 dual inhibitor peptides (2021-06-15),

9. 10799581 - PD-1 peptide inhibitors (2020-10-13),

10. 10799555 - PD-1 peptide inhibitors (2020-10-13),

11. 10501534 - Anti-malarial compositions (2019-12-10),

12. 10160802 - Anti-malarial compositions (2018-12-25),

13. 10098950 - PD-1 Peptide Inhibitors (2018-10-16),

14. 9943580 - Malaria vaccine (2018-04-17),

15. 9321834 - Anti-malarial compositions (2016-04-26),

Title: The Innovative Mind of James Pannucci

Introduction

James Pannucci, an accomplished inventor based in Reston, VA, has made significant strides in the field of biotechnology, holding a remarkable 14 patents. His work primarily focuses on developing therapeutic peptides with the potential to combat various medical conditions.

Latest Patents

Two of his latest patents include groundbreaking innovations in the realm of immunotherapy. The first is centered on LAG3 binding peptides, which provide nucleic acids encoding peptides that can inhibit the interaction between LAG3 and crucial molecules such as MHC-II, FGL1, and α-synuclein. This innovation has the potential to block the progression of hyperproliferative disorders, including cancer, as well as various infectious diseases and enhance vaccine responses. Additionally, his immunomodulatory peptides have been designed for therapeutic purposes that include treating cancer, enhancing vaccination responses, and promoting hair re-pigmentation.

Career Highlights

James Pannucci has gained experience working with notable organizations, including Leidos, Inc., and the Department of Health and Human Services of the United States. His expertise in the field has allowed him to contribute significantly to advancements in biotechnology and therapeutics through his patents.

Collaborations

Throughout his career, James has collaborated with capable individuals such as Gabriel M Gutierrez and Vinayaka Kotraiah. Their collective efforts in research and development underscore the importance of teamwork in the pursuit of innovation.

Conclusion

James Pannucci stands as an influential figure in the realm of biotechnology, with his inventions paving the way for potential breakthroughs in treatment and disease management. His commitment to innovation and collaboration drives his ongoing contributions to science and medicine, making him a noteworthy inventor in today's landscape.

This text is generated by artificial intelligence and may not be accurate.